{"id":98,"date":"2026-02-12T12:18:21","date_gmt":"2026-02-12T11:18:21","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/?page_id=98"},"modified":"2026-09-02T16:01:50","modified_gmt":"2026-09-02T14:01:50","slug":"jueves-05-de-noviembre","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/programa\/jueves-05-de-noviembre\/","title":{"rendered":"Jueves, 05 de Noviembre"},"content":{"rendered":"
\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t08:00 – 08:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tInscripci\u00f3n<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t08:30 – 08:45<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tBienvenida al Simposio e Introducci\u00f3n<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t08:45 – 10:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tMESA 1<\/strong> C\u00c1NCER DE ENDOMETRIO<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\tModerador:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t08:45 – 09:05<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tClasificaci\u00f3n molecular: del laboratorio a la toma de decisiones cl\u00ednicas. POLE, p53, MMRd y medicina personalizada. Escalada y desescalada terap\u00e9utica seg\u00fan perfil molecular. C\u00f3mo adaptar cirug\u00eda, radioterapia y tratamiento sist\u00e9mico al riesgo biol\u00f3gico<\/span>\r\n\t\t\t\tDra. Ainhoa Madariaga<\/span>\r\n\t\t\t\tHospital Universitario 12 de Octubre, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t09:05 – 09:25<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tInmunoterapia en primera l\u00ednea: \u00bfnuevo est\u00e1ndar para todos los pacientes? Lecciones tras RUBY, NRG-GY018 y estudios posteriores<\/span>\r\n\t\t\t\tDr. Ra\u00fal M\u00e1rquez<\/span>\r\n\t\t\t\tMD Anderson Cancer Center Madrid – Hospiten<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t09:25 – 09:45<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tADCs en c\u00e1ncer de endometrio: las nuevas estrellas del desarrollo cl\u00ednico. HER2, TROP2 y otras dianas emergentes<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t09:45 – 10:05<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tQuirofan\u00f3mica aplicada: el papel de la cirug\u00eda en la era molecular<\/span>\r\n\t\t\t\tDra. Ana Conde<\/span>\r\n\t\t\t\tMD Anderson Cancer Center Madrid – Hospiten<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t10:05 – 10:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t\u00c1gora<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t10:30 – 11:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tPausa caf\u00e9<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t11:00 – 12:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tMESA 2<\/strong> C\u00c1NCER DE C\u00c9RVIX<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\tModerador:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t11:00 – 11:20<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tC\u00e1ncer de c\u00e9rvix localmente avanzado a debate: controversias y oportunidades para mejorar el actual est\u00e1ndar<\/span>\r\n\t\t\t\tDr. Alejandro Gallego<\/span>\r\n\t\t\t\tCl\u00ednica Universitaria de Navarra, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t11:20 – 11:40<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tLa nueva era de la inmunoterapia en c\u00e1ncer de c\u00e9rvix metast\u00e1sico. Checkpoints, combinaciones y nuevas indicaciones<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t11:40 – 12:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tAntibody-Drug Conjugates (ADCs) en c\u00e1ncer de c\u00e9rvix: \u00bfel pr\u00f3ximo cambio de paradigma?<\/span>\r\n\t\t\t\tDr. Alejandro P\u00e9rez Fidalgo<\/span>\r\n\t\t\t\tHospital Cl\u00ednico Universitario, Valencia<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t12:00 – 12:20<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tEliminaci\u00f3n global del c\u00e1ncer de c\u00e9rvix: vacunaci\u00f3n, cribado e innovaci\u00f3n terap\u00e9utica. De la prevenci\u00f3n a la enfermedad avanzada<\/span>\r\n\t\t\t\tDra. Teresa Castellanos<\/span>\r\n\t\t\t\tCl\u00ednica Universitaria de Navarra, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t12:20 – 12:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t\u00c1gora<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n<\/div>\r\n \r\n \r\n
\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:50 – 13:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tKEYNOTE LECTURE<\/strong><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tShaping the Future in the Tailored Era. Clinical implementation of precision medicine. This is my bet<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t13:30 – 15:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tAlmuerzo<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t15:00 – 16:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tMESA 3<\/strong> C\u00c1NCER DE OVARIO<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\tModerador:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t15:00 – 15:20<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tMedicina de precisi\u00f3n en primera l\u00ednea: \u00bfestamos preparados para individualizar el tratamiento? HRD, BRCA, biomarcadores emergentes y decisiones terap\u00e9uticas<\/span>\r\n\t\t\t\tDra. Sara P\u00e9rez<\/span>\r\n\t\t\t\tHospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t15:20 – 15:40<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\t\u00bfQu\u00e9 hacer hoy despu\u00e9s de los inhibidores PARP? Nuevas estrategias en reca\u00edda platino-sensible y enfermedad platino-resistente<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t15:40 – 16:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tEl futuro del tratamiento del c\u00e1ncer de ovario: ADCs, inmunoterapia y combinaciones innovadoras. Secuenciaci\u00f3n terap\u00e9utica y ensayos en desarrollo<\/span>\r\n\t\t\t\tDr. C\u00e9sar G\u00f3mez<\/span>\r\n\t\t\t\tHospital Cl\u00ednico San Carlos, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t16:00 – 16:20<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tEl papel de los centros de alta especializaci\u00f3n y la centralizaci\u00f3n quir\u00fargica en c\u00e1ncer de ovario y otros tumores ginecol\u00f3gicos<\/span>\r\n\t\t\t\tDr. Javier de Santiago<\/span>\r\n\t\t\t\tMD Anderson Cancer Center Madrid – Hospiten<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t16:20 – 16:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t\u00c1gora<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t16:50 – 18:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tCASOS CL\u00cdNICOS \/ COMIT\u00c9 DE TUMORES \/ BURNING QUESTIONS \/ RARE TUMORS<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\tModerador:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t16:50 – 17:10<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tC\u00e1ncer de ovario<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t17:10 – 17:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tC\u00e1ncer de endometrio<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t17:30 – 17:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tC\u00e1ncer de cuello uterino<\/span>\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n\t
\r\n\t\t
\r\n\t\t\t17:50 – 18:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tCierre<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n \r\n<\/div>","protected":false},"excerpt":{"rendered":"08:00 – 08:30 Inscripci\u00f3n 08:30 – 08:45 Bienvenida al Simposio e Introducci\u00f3n 08:45 – 10:30 MESA 1 C\u00c1NCER DE ENDOMETRIO Moderador: TBC 08:45 – 09:05 Clasificaci\u00f3n molecular: del laboratorio a la toma de decisiones cl\u00ednicas. POLE, p53, MMRd y medicina personalizada. Escalada y desescalada terap\u00e9utica seg\u00fan perfil molecular. C\u00f3mo adaptar cirug\u00eda, radioterapia y tratamiento sist\u00e9mico … Leer m\u00e1s<\/a>","protected":false},"author":2,"featured_media":0,"parent":45,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-internas.php","meta":{"footnotes":""},"class_list":["post-98","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/pages\/98","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/comments?post=98"}],"version-history":[{"count":14,"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/pages\/98\/revisions"}],"predecessor-version":[{"id":198,"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/pages\/98\/revisions\/198"}],"up":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/pages\/45"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/gynecologiconcology2026\/wp-json\/wp\/v2\/media?parent=98"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}